| Literature DB >> 33708660 |
Pawan Goyal1, Aditya Gupta1, Sanjeev Srivastava1, Shilpi Modi2.
Abstract
INTRODUCTION: We aimed to analyze the difficulties and complications experienced while as a beginner in endoscopic transnasal transsphenoidal approach for pituitary adenomas.Entities:
Keywords: Adenoma; complications; endoscopic; pituitary
Year: 2020 PMID: 33708660 PMCID: PMC7869305 DOI: 10.4103/ajns.AJNS_121_20
Source DB: PubMed Journal: Asian J Neurosurg
Figure 1Endoscopic view after decongestion showing sphenoid os, sphenoethmoidal recess, and choana
Figure 2Endoscopic view showing removal of the posterior part of the tumor first
Knosp grading of cases
| Knosp grade | NF | GH secreting | PRL secreting | Corticotrophin secreting | Total, |
|---|---|---|---|---|---|
| 0 | 1 | 5 | 3 | 1 | 10 (12.04) |
| 1 | 16 | 7 | 2 | 1 | 26 (31.32) |
| 2 | 16 | 2 | 3 | 0 | 21 (25.30) |
| 3 | 10 | 2 | 5 | 0 | 17 (20.48) |
| 4 | 7 | 1 | 1 | 0 | 9 (10.84) |
NF – Nonfunctional; GH – Growth hormone; PRL – Prolactin
Hardy-Wilson grading of cases
| Grade | Grade | ||
|---|---|---|---|
| 0 | 14 (16.86) | I | 7 (8.43) |
| A | 32 (38.55) | II | 63 (75.90) |
| B | 32 (38.55) | III | 8 (9.63) |
| C | 5 (6.02) | IV | 5 (6.02) |
| D | 0 | ||
| E | 0 |
Gross total resection rate(GTR) vs Knosp grading
| Knosp grade | NF | GH secreting | PRL secreting | Corticotrophin secreting | Total, |
|---|---|---|---|---|---|
| 0 | 1 | 5 | 2 | 1 | 9 (90) |
| 1 | 15 | 6 | 2 | 0 | 23 (88.4) |
| 2 | 11 | 2 | 2 | 0 | 15 (71.42) |
| 3 | 6 | 1 | 1 | 0 | 8 (47.05) |
| 4 | 0 | 0 | 0 | 0 | 0 (0) |
NF – Nonfunctional; GH – Growth hormone; PRL – Prolactin
Analysis of remission rate in functional adenomas
| Tumor type | Gross total removal | Remission rate (%) |
|---|---|---|
| GH secreting | 14 | 8 (57.1) |
| PRL secreting | 7 | 5 (71.4) |
| Corticotrophin secreting | 1 | 1 (100) |
| Total | 22 | 14 (63.6) |
GH – Growth hormone; PRL – Prolactin
Surgical complications in this series
| Complications | |
|---|---|
| Nasal | 6 |
| Septal hematoma | 1 (1.2) |
| Epistaxis | 3 (3.6) |
| Hyposmia | 2 (2.4) |
| Sphenoid sinus | 2 |
| Sinusitis | 2 (2.4) |
| Sellar and suprasellar | 10 |
| Postoperative CSF leak | 6 (7.2) |
| Meningitis | 2 (2.4) |
| SAH | 1 (1.2) |
| Sellar hematoma | 1 (1.2) |
| Endocrine | 15 |
| Anterior pituitary insufficiency | 5 (6.02) |
| Posterior pituitary insufficiency | 10 (12.04) |
| Temporary | 9 (10.84) |
| Permanent | 1 (1.2) |
CSF – Cerebrospinal fluid; SAH – Subarachnoid hemorrhage
Figure 3Postoperative computed tomography showing subarachnoid hemorrhage in the interpeduncular cistern
Figure 4Pre- and post-operative computed tomography images of sellar hematoma
Comparison of complications amongst major endoscopic pituitary series in literature
| Complications | Cappabianca | Berker | de Divitiis | Zhou | Charalampaki | Jho[ | Gondim | Dehdashti | Present study |
|---|---|---|---|---|---|---|---|---|---|
| Epistaxis | 1.3 | 0.6 | 1.7 | 1.6 | 1.4 | 1.9 | 1 | 3.6 | |
| Hyposmia | - | 0.6 | - | - | 2.2 | None | - | 2.4 | |
| CSF leak | 2 | 1.2 | 2.1 | 0.5 | 3.7 | 6 | 2.6 | 3 | 7.2 |
| Sinusitis | 2 | 0.4 | 2.1 | - | 1.4 | 1.2 | 1.6 | - | 2.4 |
| Meningitis | 0.6 | 0.7 | 0.4 | 0.8 | - | 1.2 | 0.6 | 1 | 2.4 |
| Anterior pituitary deficiency | 3.42 | 1.92 | 14.5 | - | 4.4 | 11 | 11.6 | 3 | 6.02 |
| DI | 13.6 | 4.6 | 3.1 | 3.7 | 5.9 | 3 | 6.3 | 1 | 12.04 |
| Vascular injury | 0.6 | 0.16 | 0.4 | - | 0.7 | - | 1 | - | None |
| Death | 0.68 | None | 0.4 | None | 0.7 | - | 1 | None | None |
DI – Diabetes insipidus; CSF – Cerebrospinal fluid
Analysis of learning curve
| First half | Second half | ||
|---|---|---|---|
| Number of cases | 41 | 41 | |
| Gross total removal (%) | 26 (63.4) | 29 (70.7) | 0.48 |
| Invasive tumor* | 34 | 38 | |
| Gross total removal in invasive tumor (%) | 19 (55.88) | 27 (71.05) | 0.18 |
| Severe complications** | 8 | 4 | 0.21 |
| Gross total removal in functional adenomas | 12 | 10 | |
| Endocrine remission in functional adenomas with gross total removal (%) | 7 (58.33) | 7 (70) | 0.89 |
*Invasive tumor (above Knosp grade 0); **Severe complications (which lead to reexploration or prolonged hospital stay or permanent morbidity)